Thalys Sampaio Rodrigues

Dr. Thalys Sampaio Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
BCBenjamin Cailes
Benjamin Cailes
EHEva-Louise Huber
Eva-Louise Huber
CBClaudia Brick
Claudia Brick
OFOmar Farouque
Omar Farouque
AMAvik Majumdar
Avik Majumdar
AKAnoop N. Koshy
Anoop N. Koshy
Cirrhotic cardiomyopathy (CCM) is an underrecognized risk factor for cardiac events in patients undergoing liver transplantation (LT). Blunted cardiac reserve (BCR) is an emerging indicator of CCM, although it has not been integrated into diagnostic guidelines. This study assesses post-transplant cardiac outcomes and mortality in patients with BCR compared to current CCM diagnostic guidelines, focusing on diastolic indices. Consecutive patients undergoing liver transplant assessment were included. Of 978 patients screened with dobutamine stress echocardiography between 2010-2023, 481 (58.0%) progressed to LT, with 183 (38.0%) meeting BCR criteria and 117 (24.3%) meeting existing CCM diagnostic criteria. Thirty (6.2%) patients suffered a 30-day major adverse cardiovascular event (MACE), and 92 patients (19.1%) died on long-term follow-up. Following multivariate regression analysis, BCR was the strongest independent risk factor for post-operative MACE (HR 2.57 (1.13-5.85), p=0.024), heart failure exacerbations (HR 6.93 (1.46-33.01), p=0.015), and 30-day mortality (HR 9.69 (1.04-92.33), p=0.049). Addition of BCR to the existing guidelines improved MACE prediction (HR 5.81 (1.71-19.76) vs 2.59 (1.15-5.87), p=0.006), with a net reclassification improvement index of 41.9% (p=0.004) compared to existing guidelines alone. These results support the integration of a cardiac reserve assessment into CCM diagnostic criteria, and use in risk stratification of patients undergoing LT.

13 February 2024 in American Heart Journal
Verified
Journal Article
Open access
TRThalys Sampaio Rodrigues
Thalys Sampaio Rodrigues
LQLevindo Jose Garcia Quarto
Levindo Jose Garcia Quarto
SNSavio Carvalho Nogueira
Savio Carvalho Nogueira
JTJames D. Theuerle
James D. Theuerle
OFOmar Farouque
Omar Farouque
AKAnoop N. Koshy
Anoop N. Koshy
Early decongestion therapy with intravenous diuretics may be associated with improved outcomes in acute heart failure (AHF), however data is conflicting. This meta-analysis sought to evaluate the impact of door-to-IV diuretic (D2D) time on mortality in patients with AHF. Pooled estimates from observational studies comprising 28,124 patients, early IV diuresis (reference time 30-105 minutes) was associated with a 23% reduction in 30-day mortality in AHF (OR 0.77; 95% CI 0.64-0.93), despite no significant in-hospital death reduction (OR 0.84; 95% CI 0.57-1.24).

25 August 2023 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
SSSimon Stewart
Simon Stewart
SPSheila Patel
Sheila Patel
TLTerase F Lancefield
Terase F Lancefield
TRThalys Sampaio Rodrigues
Thalys Sampaio Rodrigues
NDNicholas Doumtsis
Nicholas Doumtsis
LBLouise M Burrell
Louise M Burrell
Aims: We aimed to recruit a representative cohort of women and men with multi-morbid chronic heart disease as part of a trial testing an innovative, nurse-co-ordinated, multi-faceted intervention to lower rehospitalization and death by addressing areas of vulnerability to external challenges to their health. Methods and results: The prospective, randomized open, blinded end-point RESILIENCE Trial recruited 203 hospital inpatients (mean age 75.7 ± 10.2 years) of whom 51% were women and 94% had combined coronary artery disease, heart failure, and/or atrial fibrillation. Levels of concurrent multi-morbidity were high (mean Charlson Index of Comorbidity Score 6.5 ± 2.7), and 8.9% had at least mild frailty according to the Rockwood Clinical Frailty Scale. Including the index admission, 19–20% of women and men had a pre-existing pattern of seasonally linked hospitalization (seasonality). Detailed phenotyping revealed that 48% of women and 40% of men had ≥3 physiological factors, and 15% of women and 16% of men had ≥3 behavioural factors likely to increase their vulnerability to external provocations to their health. Overall, 61–62% of women and men had ≥4 combined factors indicative of such vulnerability. Additional factors such as reliance on the public health system (63 vs. 49%), lower education (30 vs. 14%), and living alone (48 vs. 29%) were more prevalent in women. Conclusion: We successfully recruited women and men with multi-morbid chronic heart disease and bio-behavioural indicators of vulnerability to external provocations to their health. Once completed, the RESILIENCE TRIAL will provide important insights on the impact of addressing such vulnerability (promoting resilience) on subsequent health outcomes. Registration: ClinicalTrials.org: NCT04614428.

3 June 2025 in Liver Transplantation
Verified
Journal Article
Open access
BCBenjamin Cailes
Benjamin Cailes
NKNuman Kutaiba
Numan Kutaiba
OFOmar Farouque
Omar Farouque
AMAvik Majumdar
Avik Majumdar
TRThalys Sampaio Rodrigues
Thalys Sampaio Rodrigues
AKAnoop N. Koshy
Anoop N. Koshy
Cardiovascular (CV) disease is a leading cause of postoperative mortality following liver transplantation (LT). The presence of abdominal aortic calcification (AAC) has been linked to CV events in the general population. We sought to investigate whether AAC on routine pre-transplant CT can improve the prediction of coronary artery disease, post-LT major adverse cardiovascular events (MACEs) or long-term mortality. Of 461 patients undergoing LT between 2010 and 2018, 318 were included in the analysis, among whom 81 had also undergone computed tomography coronary angiography. The extent of AAC was quantified with high AAC defined as a calcium score ≥500. High AAC was identified in 84/318 (26.4%) and demonstrated moderate correlation with coronary artery calcium score (CACS) ( r =0.52, p <0.001). Thirty-two MACE events occurred in 28 patients (8.8%) within 30 days. High AAC was a strong independent predictor of moderate-to-severe coronary disease on CT coronary angiography (OR 12.6, 95% CI 1.5–103.0, p =0.02). It was also associated with a significantly increased risk of 30-day MACE (OR 2.34, 95% CI 1.08–5.05, p =0.03) and long-term mortality (HR 2.45, 95% CI 1.18–5.06, p =0.02). Following multivariate analysis adjusting for pertinent CV risk factors, high AAC remained a strong independent predictor of MACE (OR 3.10, 95% CI 1.27–7.60, p =0.02). Addition of AAC to the Revised Cardiac Risk Index significantly improved model fit for predicting MACE outcomes ( p <0.01), while the absence of heavy AAC ruled out moderate-to-severe disease on CT coronary angiography with a negative predictive value of 97.0%. High AAC on routine CT scans was associated with a 3-fold increased risk of 30-day MACE post-LT and improved CV risk prediction compared to traditional indices. Quantification of AAC may offer a simple method of improving CV risk assessment in these patients.

27 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAMeor Azraai
Meor Azraai
DMDaisuke Miura
Daisuke Miura
YLYuan-Hong Lin
Yuan-Hong Lin
TRThalys Sampaio Rodrigues
Thalys Sampaio Rodrigues
VNVoltaire Nadurata
Voltaire Nadurata
Aims: To investigate the incidence of cardiac implantable electronic devices (CIED) malfunction with radiotherapy (RT) treatment and assess predictors of CIED malfunction. Methods: A 6-year retrospective analysis of patients who underwent RT with CIED identified through the radiation oncology electronic database. Clinical, RT (cumulative dose, dose per fraction, beam energy, beam energy dose, and anatomical area of RT) and CIED details (type, manufacturer, and device malfunction) were collected from electronic medical records. Results: We identified 441 patients with CIED who underwent RT. CIED encountered a permanent pacemaker (PPM) (78%), cardiac resynchronization therapy—pacing (CRT-P) (2%), an implantable cardioverter defibrillator (ICD) (10%), and a CRT-defibrillator (CRT-D) (10%). The mean cumulative dose of RT was 36 gray (Gy) (IQR 1.8–80 Gy) and the most common beam energy used was photon ≥10 megavolt (MV) with a median dose of 7 MV (IQR 5–18 MV). We further identified 17 patients who had CIED malfunction with RT. This group had a higher cumulative RT dose of 42.5 Gy (20–77 Gy) and a photon dose of 14 MV (12–18 MV). None of the malfunctions resulted in clinical symptoms. Using logistic regression, the predictors of CIED malfunction were photon beam energy use ≥10 MV (OR 5.73; 95% CI, 1.58–10.76), anatomical location of RT above the diaphragm (OR 5.2, 95% CI, 1.82–15.2), and having a CIED from the ICD group (OR 4.6, 95% CI, 0.75–10.2). Conclusion: Clinicians should be aware of predictors of CIED malfunction with RT to ensure the safety of patients.

1 October 2018 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
TRThalys Sampaio Rodrigues
Thalys Sampaio Rodrigues
LQLevindo José Garcia Quarto
Levindo José Garcia Quarto